MGX

Metagenomi, Inc. - Common Stock (MGX)

About Metagenomi, Inc. - Common Stock (MGX)

Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene edit­ing toolbox, ther­a­peu­tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.

Details

Daily high
$1.76
Daily low
$1.52
Price at open
$1.53
52 Week High
$8.40
52 Week Low
$1.23
Market cap
56.8M
Dividend yield
0.00%
Volume
360,207
Avg. volume
434,778
P/E ratio
-.58

Metagenomi, Inc. - Common Stock News

Details

Daily high
$1.76
Daily low
$1.52
Price at open
$1.53
52 Week High
$8.40
52 Week Low
$1.23
Market cap
56.8M
Dividend yield
0.00%
Volume
360,207
Avg. volume
434,778
P/E ratio
-.58